Sign In
Buy HUGE
$0.0899
+0 (+0%)
At Close: Nov 15, 2024
FSD Pharma Announces Appointment of Interim Chief Financial Officer
08:30am, Wednesday, 05'th May 2021
TORONTO--(BUSINESS WIRE)---- $HUGE--FSD Pharma Inc. (Nasdaq:HUGE) (CSE:HUGE) (the "Company" or "FSD Pharma") is pleased to announce the appointment of Nathan Coyle, the Company's Corporate Controller
FSD Pharma Issues Important Message to Shareholders and Response to Dissident Circular
07:30am, Monday, 03'rd May 2021
TORONTO--(BUSINESS WIRE)---- $HUGE--FSD Pharma Inc. (Nasdaq:HUGE) (CSE:HUGE) (the "Company" or "FSD Pharma") wishes to alert you to the events that have occurred since the Company filed its Management
These 10 Pot Stocks Smoked the Last Week of April
02:47pm, Friday, 30'th Apr 2021
Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week, and look ahead to how the cannabis industry will co
Toronto, Ontario--(Newsfile Corp. - April 26, 2021) - On Monday, April 26, 2021, the group of concerned shareholders (the "Concerned Shareholders") of FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FSE:
FSD Pharma throws resources behind legacy anti-inflammatory drug as potential coronavirus therapy
06:01am, Thursday, 22'nd Apr 2021
Focused on lead anti-inflammatory drug FSD-201 Launched Phase 2 study of drug known as micro PEA in December 2020 Developing drugs to treat gastrointestinal diseases in dogs and cats What FSD Pharm
These 9 Cannabis Stocks Caught Fire This Week
07:00am, Monday, 12'th Apr 2021
Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week, and look ahead to how the cannabis industry will co
FSD Pharma Inc. Management Wasting Company Money by Seeking to Further Delay Shareholder Meeting
07:30am, Monday, 05'th Apr 2021
TORONTO, April 5, 2021 /PRNewswire/ - On Tuesday, March 30, 2021, Anthony Durkacz, a founding director and member of the group of concerned shareholders, which also includes founding shareholder Zeesh
The Week Where New York Legalizes Recreational Marijuana
02:33pm, Thursday, 01'st Apr 2021
Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week, and look ahead to how the cannabis industry will co
FSD Pharma Pivots From Cannabis To COVID-19 Treatment
08:02pm, Sunday, 28'th Mar 2021
FSD Pharma is a biopharmaceutical research company specializing in medical applications of cannabinoids. The company found a possible treatment for COVID-19 and is attempting a Phase II study.
Why Bluebird Bio, Onconova, FSD Pharma, Immatics Are Moving Wednesday
11:23am, Wednesday, 17'th Mar 2021
bluebird bio, Inc. (NASDAQ: BLUE), Onconova Therapeutics, Inc. (NASDAQ: ONTX), FSD Pharma Inc. (NASDAQ: HUGE) and Immatics N.V. (NASDAQ: IMTX) are among the biggest biopharma movers in Wednesday's ses
FSD Pharma in license agreement with Innovet Italia to develop FDA-approved drugs to treat gastrointestinal diseases in dogs and cats
09:57am, Wednesday, 17'th Mar 2021
FSD Pharma Inc (NASDAQ:HUGE) (CSE:HUGE) (FRA:0K9A) has entered into a license agreement with Innovet Italia SRL to develop US Food and Drug Administration-approved veterinary drugs for the treatment o
HUGE Stock: Why Pet Care Play FSD Pharma Is Soaring Today
09:16am, Wednesday, 17'th Mar 2021
HUGE stock is on the move Wednesday after FSD Pharma announced a potentially lucrative move in the pet care market. Here's what to know.
HUGE Stock Price Increases Over 50% Pre-Market: Why It Happened
06:24am, Wednesday, 17'th Mar 2021
The stock price of FSD Pharma Inc (NYSE: HUGE) has increased by over 50% pre-market. This is why it happened.
TORONTO--(BUSINESS WIRE)---- $HUGE--FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE) (“FSD Pharma” or the “Company”) today announces that it has entered into a license agreement (the “License Agre
Toronto, Ontario--(Newsfile Corp. - March 8, 2021) - The group of concerned shareholders (the "Concerned Shareholders") of FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FSE: 0K9) (the "Company" or "FSD"
